VAERS reports by lot

Moderna COVID-19 lot 03A21A: VAERS reports

39 VAERS reports list lot 03A21A as a Moderna COVID-19 vaccine, received between 2021-03-01 and 2022-10-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
39
Reports
5%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3625%
Injection-site / Local reaction2215%
Neurological2115%
Musculoskeletal1611%
Gastrointestinal118%
Dermatological (non-injection-site)107%
Allergic / Anaphylactic96%
Respiratory75%
Psychiatric / Neuropsychiatric53%
Cardiac / Cardiovascular32%
Thrombotic / Hematological21%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Florida4
North Carolina3
Tennessee3
Ohio3
Michigan3
Washington3
Pennsylvania2
Illinois2
Maryland2
Texas2
New Jersey1

Reports by month received

2021-0310
2021-0410
2021-054
2021-089
2021-111
2022-021
2022-032
2022-051
2022-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.